Sirolimus as primary immunosuppression is effective in attenuating progression of cardiac-allograft vasculopathy.
Madsen
Joren C
JC
Massachusetts General Hospital, Department of Surgery, Cox 654, 55 Fruit Street, Boston, MA 02114, USA. madsen@helix.mgh.harvard.edu